Evotec SE (EVT.DE)
EUR 8.5
(-4.23%)
EUR 8.5
(-4.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 115.28 Million EUR | 25.97% |
| 2022 | 91.51 Million EUR | 149.1% |
| 2021 | -186.4 Million EUR | -367.06% |
| 2020 | 69.8 Million EUR | -62.49% |
| 2019 | 186.06 Million EUR | 3339.28% |
| 2018 | 5.41 Million EUR | -95.6% |
| 2017 | 122.91 Million EUR | 323.02% |
| 2016 | -55.11 Million EUR | -155.7% |
| 2015 | -21.55 Million EUR | 20.64% |
| 2014 | -27.16 Million EUR | 4.37% |
| 2013 | -28.4 Million EUR | -31.11% |
| 2012 | -21.66 Million EUR | -1936.0% |
| 2011 | -1.06 Million EUR | 87.12% |
| 2010 | -8.26 Million EUR | 58.11% |
| 2009 | -19.72 Million EUR | 54.91% |
| 2008 | -43.73 Million EUR | -66.11% |
| 2007 | -26.33 Million EUR | 60.59% |
| 2006 | -66.81 Million EUR | -66.02% |
| 2005 | -40.24 Million EUR | -2598.26% |
| 2004 | -1.49 Million EUR | -469.06% |
| 2003 | 404.16 Thousand EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| 2001 | - EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 199.24 Million EUR | 72.82% |
| 2024 Q2 | 251.62 Million EUR | 26.29% |
| 2023 Q1 | 718.48 Million EUR | 685.07% |
| 2023 Q4 | 115.28 Million EUR | 28.99% |
| 2023 Q3 | 89.37 Million EUR | 20.14% |
| 2023 Q2 | 74.39 Million EUR | -89.65% |
| 2023 FY | 115.28 Million EUR | 25.97% |
| 2022 FY | 91.51 Million EUR | 149.1% |
| 2022 Q1 | -141.92 Million EUR | 23.87% |
| 2022 Q3 | 28.17 Million EUR | 113.18% |
| 2022 Q4 | 91.51 Million EUR | 224.78% |
| 2022 Q2 | -213.86 Million EUR | -50.69% |
| 2021 Q3 | 167.2 Million EUR | 28.08% |
| 2021 Q1 | 115.48 Million EUR | 65.44% |
| 2021 FY | -186.4 Million EUR | -367.06% |
| 2021 Q2 | 130.54 Million EUR | 13.05% |
| 2021 Q4 | -186.4 Million EUR | -211.48% |
| 2020 Q3 | 238.76 Million EUR | -10.05% |
| 2020 FY | 69.8 Million EUR | -62.49% |
| 2020 Q1 | 173.99 Million EUR | -6.49% |
| 2020 Q2 | 265.43 Million EUR | 52.55% |
| 2020 Q4 | 69.8 Million EUR | -70.77% |
| 2019 Q3 | 188.91 Million EUR | 62.93% |
| 2019 Q2 | 115.95 Million EUR | 0.32% |
| 2019 FY | 186.06 Million EUR | 3339.28% |
| 2019 Q4 | 186.06 Million EUR | -1.51% |
| 2019 Q1 | 115.57 Million EUR | 2036.4% |
| 2018 FY | 5.41 Million EUR | -95.6% |
| 2018 Q2 | 65.15 Million EUR | -48.06% |
| 2018 Q3 | 14.54 Million EUR | -77.68% |
| 2018 Q1 | 125.45 Million EUR | 2.07% |
| 2018 Q4 | 5.41 Million EUR | -62.81% |
| 2017 Q3 | 114.92 Million EUR | 243.53% |
| 2017 FY | 122.91 Million EUR | 323.02% |
| 2017 Q1 | -69.29 Million EUR | -25.72% |
| 2017 Q2 | -80.06 Million EUR | -15.55% |
| 2017 Q4 | 122.91 Million EUR | 6.95% |
| 2016 FY | -55.11 Million EUR | -155.7% |
| 2016 Q4 | -55.11 Million EUR | -15.63% |
| 2016 Q3 | -47.66 Million EUR | -20.01% |
| 2016 Q2 | -39.71 Million EUR | -49.7% |
| 2016 Q1 | -26.53 Million EUR | -23.09% |
| 2015 Q1 | -27.05 Million EUR | 0.4% |
| 2015 FY | -21.55 Million EUR | 20.64% |
| 2015 Q3 | -26.42 Million EUR | 27.59% |
| 2015 Q4 | -21.55 Million EUR | 18.44% |
| 2015 Q2 | -36.49 Million EUR | -34.91% |
| 2014 Q3 | -33.74 Million EUR | -56.08% |
| 2014 Q4 | -27.16 Million EUR | 19.51% |
| 2014 FY | -27.16 Million EUR | 4.37% |
| 2014 Q1 | -21.46 Million EUR | 24.43% |
| 2014 Q2 | -21.62 Million EUR | -0.72% |
| 2013 Q1 | -23.23 Million EUR | -7.24% |
| 2013 Q3 | -24.39 Million EUR | -26.08% |
| 2013 Q2 | -19.35 Million EUR | 16.7% |
| 2013 FY | -28.4 Million EUR | -31.11% |
| 2013 Q4 | -28.4 Million EUR | -16.41% |
| 2012 FY | -21.66 Million EUR | -1936.0% |
| 2012 Q2 | 2.75 Million EUR | -69.64% |
| 2012 Q4 | -21.66 Million EUR | -22.27% |
| 2012 Q1 | 9.07 Million EUR | 952.54% |
| 2012 Q3 | -17.71 Million EUR | -743.32% |
| 2011 Q1 | -26.52 Million EUR | -221.08% |
| 2011 Q3 | -14.22 Million EUR | -30.72% |
| 2011 Q4 | -1.06 Million EUR | 92.52% |
| 2011 FY | -1.06 Million EUR | 87.12% |
| 2011 Q2 | -10.88 Million EUR | 58.98% |
| 2010 Q4 | -8.26 Million EUR | -111.2% |
| 2010 FY | -8.26 Million EUR | 58.11% |
| 2010 Q3 | -3.91 Million EUR | 81.02% |
| 2010 Q2 | -20.61 Million EUR | -74.1% |
| 2010 Q1 | -11.84 Million EUR | 39.96% |
| 2009 Q3 | -21.58 Million EUR | 26.74% |
| 2009 Q2 | -29.45 Million EUR | 7.11% |
| 2009 Q1 | -31.71 Million EUR | 27.49% |
| 2009 FY | -19.72 Million EUR | 54.91% |
| 2009 Q4 | -19.72 Million EUR | 8.61% |
| 2008 FY | -43.73 Million EUR | -66.11% |
| 2008 Q2 | -29.9 Million EUR | 0.0% |
| 2008 Q4 | -43.73 Million EUR | -84.53% |
| 2008 Q3 | -23.7 Million EUR | 20.76% |
| 2007 Q3 | -14.93 Million EUR | 0.0% |
| 2007 FY | -26.33 Million EUR | 60.59% |
| 2007 Q4 | -25.82 Million EUR | -72.93% |
| 2006 Q1 | -56.87 Million EUR | -1715.85% |
| 2006 Q3 | -41.07 Million EUR | 13.45% |
| 2006 Q4 | -45.17 Million EUR | -9.96% |
| 2006 FY | -66.81 Million EUR | -66.02% |
| 2006 Q2 | -47.46 Million EUR | 16.56% |
| 2005 Q1 | -1.79 Million EUR | -20.56% |
| 2005 Q4 | -3.13 Million EUR | 0.0% |
| 2005 FY | -40.24 Million EUR | -2598.26% |
| 2005 Q2 | -517.85 Thousand EUR | 71.2% |
| 2004 Q4 | -1.49 Million EUR | 0.0% |
| 2004 FY | -1.49 Million EUR | -469.06% |
| 2004 Q2 | -2.59 Million EUR | -63.71% |
| 2004 Q1 | -1.58 Million EUR | -492.41% |
| 2003 Q4 | 404.16 Thousand EUR | 0.0% |
| 2003 FY | 404.16 Thousand EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| 2001 FY | - EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| MPH Health Care AG | 8.5 Million EUR | -1255.937% |
| Apontis Pharma AG | -20.8 Million EUR | 654.274% |
| Dermapharm Holding SE | 921.66 Million EUR | 87.491% |
| MERCK Kommanditgesellschaft auf Aktien | 7.95 Billion EUR | 98.551% |
| PharmaSGP Holding SE | 33.21 Million EUR | -247.141% |
| SynBiotic SE | 3.59 Million EUR | -3110.461% |